• 1
    KelleyWN, HarrisEDJr, RuddyS, SledgeCB, editors. Textbook of rheumatology. 5th ed. Vols. 1 and 2. Philadelphia: WB Saunders; 1997.
  • 2
    Jasin HE, Noyori K, Takagi T, Taurog JD. Characteristics of anti–type II collagen antibody binding to articular cartilage. Arthritis Rheum 1993; 36: 6519.
  • 3
    Noyori K, Jasin HE. Inhibition of human fibroblast adhesion by cartilage surface proteoglycans. Arthritis Rheum 1994; 37: 165663.
  • 4
    Jasin HE, Taurog JD. Mechanisms of disruption of the articular cartilage surface in inflammation. Neutrophil elastase increases availability of collagen type II epitopes for binding with antibody on the surface of articular cartilage. J Clin Invest 1991; 87: 15316.
  • 5
    Noyori K, Jasin HE. Repair characteristics of the articular cartilage surface following acute inflammatory arthritis. J Rheumatol 1994; 21: 17313.
  • 6
    Noyori K, Koshino T, Takagi T, Okamoto R, Jasin HE. Binding characteristics of antitype II collagen antibody to the surface of diseased human cartilage as a probe for tissue damage. J Rheumatol 1994; 21: 2936.
  • 7
    Greenbury CL, Skingle J. Anti-cartilage antibody. J Clin Pathol 1979; 32: 82631.
  • 8
    Clague RB, Moore LJ. IgG and IgM antibody to native type II collagen in rheumatoid arthritis serum and synovial fluid: evidence for the presence of collagen-anticollagen immune complexes in synovial fluid. Arthritis Rheum 1984; 27: 13707.
  • 9
    Stuart JM, Huffstutter EH, Townes AS, Kang AH. Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 125I-radioimmunoassay. Arthritis Rheum 1983; 26: 83240.
  • 10
    Terato K, Shimozuru Y, Katayama K, Takemitsu Y, Yamashita I, Miyatsu M, et al. Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum 1990; 33: 1493500.
  • 11
    Cook AD, Rowley MJ, Mackay IR, Gough A, Emery P. Antibodies to type II collagen in early rheumatoid arthritis: correlation with disease progression. Arthritis Rheum 1996; 39: 17207.
  • 12
    Tarkowski A, Klareskog L, Carlsten H, Herberts P, Koopman WJ. Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum 1989; 32: 108792.
  • 13
    Ronnelid J, Lysholm J, Engstrom-Laurent A, Klareskog L, Heyman B. Local anti–type II collagen antibody production in rheumatoid arthritis synovial fluid: evidence for an HLA–DR4–restricted IgG response. Arthritis Rheum 1994; 37: 10239.
  • 14
    Emmrich F, Wang J. Frequencies of autoreactive collagen type II specific B-cells in rheumatoid arthritis. Scand J Rheumatol Suppl 1995; 101: 3941.
  • 15
    Kim WU, Yoo WH, Park W, Kang YM, Kim SI, Park JH, et al. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. J Rheumatol 2000; 27: 57581.
  • 16
    Kim WU, Cho ML, Jung YO, Min SY, Park SW, Min DJ, et al. Type II collagen autoimmunity in rheumatoid arthritis. Am J Med Sci 2004; 327: 20211.
  • 17
    Morgan K, Clague RB, Collins I, Ayad S, Phinn SD, Holt PL. Incidence of antibodies of native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis. Ann Rheum Dis 1987; 46: 9027.
  • 18
    Choi EK, Gatenby PA, McGill NW, Bateman JF, Cole WG, York JR. Autoantibodies to type II collagen: occurrence in rheumatoid arthritis, other arthritides, autoimmune connective tissue diseases, and chronic inflammatory syndromes. Ann Rheum Dis 1988; 47: 31322.
  • 19
    Myers LK, Rosloniec EF, Cremer MA, Kang AH. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci 1997; 61: 186178.
  • 20
    Holmdahl R, Bockermann R, Backlund J, Yamada H. The molecular pathogenesis of collagen-induced arthritis in mice—a model for rheumatoid arthritis. Ageing Res Rev 2002; 1: 13547.
  • 21
    Stuart JM, Cremer MA, Townes AS, Kang AH. Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med 1982; 155: 116.
  • 22
    Stuart JM, Tomoda K, Yoo TJ, Townes AS, Kang AH. Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum 1983; 26: 123744.
  • 23
    Wooley PH, Luthra HS, Krco CJ, Stuart JM, David CS. Type II collagen–induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti–type II collagen antibody or free native type II collagen. Arthritis Rheum 1984; 27: 10107.
  • 24
    Holmdahl R, Rubin K, Klareskog L, Larsson E, Wigzell H. Characterization of the antibody response in mice with type II collagen–induced arthritis, using monoclonal anti–type II collagen antibodies. Arthritis Rheum 1986; 29: 40010.
  • 25
    Holmdahl R, Jansson L, Larsson A, Jonsson R. Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies. Scand J Immunol 1990; 31: 14757.
  • 26
    Loutis N, Bruckner P, Pataki A. Induction of erosive arthritis in mice after passive transfer of anti-type II collagen antibodies. Agents Actions 1988; 25: 3529.
  • 27
    Terato K, Hasty KA, Reife RA, Cremer MA, Kang AH, Stuart JM. Induction of arthritis with monoclonal antibodies to collagen. J Immunol 1992; 148: 21038.
  • 28
    Buckee C, Morgan K, Ayad S, Collins I, Clague RB, Holt PJ. Diversity of antibodies to type II collagen in patients with rheumatoid arthritis: detection by binding to α-chains and to cyanogen bromide peptides. Br J Rheumatol 1990; 29: 2548.
  • 29
    Rowley MJ, Mackay IR, Brand CA, Bateman JF, Chan D. Epitope specificity of antibodies to type II collagen in rheumatoid arthritis and systemic lupus erythematosus. Rheumatol Int 1992; 12: 659.
  • 30
    Cook AD, Rowley MJ, Stockman A, Muirden KD, Mackay IR. Specificity of antibodies to type II collagen in early rheumatoid arthritis. J Rheumatol 1994; 21: 118691.
  • 31
    Burkhardt H, Koller T, Engstrom A, Nandakumar KS, Turnay J, Kraetsch HG, et al. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum 2002; 46: 233948.
  • 32
    Seki N, Sudo Y, Yoshioka T, Sugihara S, Fujitsu T, Sakuma S, et al. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol 1988; 140: 147784.
  • 33
    Taylor PC, Plater-Zyberk C, Maini RN. The role of the B cells in the adoptive transfer of collagen-induced arthritis from DBA/1 (H-2q) to SCID (H-2d) mice. Eur J Immunol 1995; 25: 7639.
  • 34
    Ronnelid J, Tejde A, Mathsson L, Nilsson-Ekdahl K, Nilsson B. Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcγRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE. Ann Rheum Dis 2003; 62: 3742.
  • 35
    Mathsson L, Tejde A, Carlson K, Hoglund M, Nilsson B, Nilsson-Ekdahl K, et al. Cryoglobulin-induced cytokine production via FcγRIIa: inverse effects of complement blockade on the production of TNF-α and IL-10. Implications for the growth of malignant B-cell clones. Br J Haematol 2005; 129: 8308.
  • 36
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 37
    Tejde A, Mathsson L, Ekdahl KN, Nilsson B, Ronnelid J. Immune complex-stimulated production of interleukin-12 in peripheral blood mononuclear cells is regulated by the complement system. Clin Exp Immunol 2004; 137: 5218.
  • 38
    Van Den Herik-Oudijk IE, Westerdaal NA, Henriquez NV, Capel PJ, Van De Winkel JG. Functional analysis of human FcγRII (CD32) isoforms expressed in B lymphocytes. J Immunol 1994; 152: 57485.
  • 39
    Vely F, Gruel N, Moncuit J, Cochet O, Rouard H, Dare S, et al. A new set of monoclonal antibodies against human FcγRII (CD32) and FcγRIII (CD16): characterization and use in various assays. Hybridoma 1997; 16: 51928.
  • 40
    Perussia B, Trinchieri G, Jackson A, Warner NL, Faust J, Rumpold H, et al. The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol 1984; 133: 1809.
  • 41
    Radstake T, van Lent PL, Pesman GJ, Blom AB, Sweep FG, Ronnelid J, et al. High production of proinflammatory and Th1 cytokines by dendritic cells from patients with rheumatoid arthritis, and down regulation upon FcγR triggering. Ann Rheum Dis 2004; 63: 696702.
  • 42
    Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 27381.
  • 43
    Blom AB, Radstake TR, Holthuysen AE, Sloetjes AW, Pesman GJ, Sweep FG, et al. Increased expression of Fcγ receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor α and matrix metalloproteinase. Arthritis Rheum 2003; 48: 100214.
  • 44
    Berger S, Ballo H, Stutte HJ. Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: a network of pro- and antiinflammatory cytokines dependent on the antigen-antibody ratio. Eur J Immunol 1996; 26: 1297301.
  • 45
    Tan Sardjono C, Mottram PL, Hogarth PM. The role of FcγRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosus. Immunol Cell Biol 2003; 81: 37481.
    Direct Link:
  • 46
    Blom AB, van Lent PL, van Vuuren H, Holthuysen AE, Jacobs C, van de Putte LB, et al. FcγR expression on macrophages is related to severity and chronicity of synovial inflammation and cartilage destruction during experimental immune-complex-mediated arthritis (ICA). Arthritis Res 2000; 2: 489503.
  • 47
    Kleinau S, Martinsson P, Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct Fcγ receptors. J Exp Med 2000; 191: 16116.
  • 48
    Kagari T, Tanaka D, Doi H, Shimozato T. Essential role of Fcγ receptors in anti-type II collagen antibody-induced arthritis. J Immunol 2003; 170: 431824.
  • 49
    Holmdahl R, Jansson L, Andersson M, Larsson E. Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis. Immunology 1988; 65: 30510.
  • 50
    Tan Sardjono C, Mottram PL, van de Velde NC, Powell MS, Power D, Slocombe RF, et al. Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcγ receptor IIa–transgenic mice. Arthritis Rheum 2005; 52: 32209.